STXS (Stereotaxis) Tariff Resilience Score: 4/10 (As of Jul. 01, 2026)


STXS Stereotaxis Inc STXS
68 GF Score
Price $1.77
GF Value $2.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Tariff Resilience Score?

Stereotaxis STXS +2.91% 68 Tariff Resilience Score is 4 as of Jul. 01, 2026. GuruFocus rates STXS with a GF Score™ of 68/100 and a GF Value™ of $2.32 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Stereotaxis ranks better than 69.93% on this metric.

Stereotaxis has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Stereotaxis has Medical device company with a global supply chain and international sales. Vulnerable to tariffs on medical equipment, but potential exemptions and strategic supplier relationships offer some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Stereotaxis might have Average Resilient.


Stereotaxis  (AMEX:STXS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Stereotaxis Tariff Resilience Score Related Terms


STXS vs PDEX, KRMD, EMBC: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Tariff Resilience Score falls into.


STXS
68GF Score
Stereotaxis Inc STXS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Stereotaxis (STXS) has a Tariff Resilience Score of 4 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Stereotaxis ranks #252 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 30.1%.
Is Stereotaxis' Tariff Resilience Score too high?
Stereotaxis' current Tariff Resilience Score is 4. Based on the distribution chart, Stereotaxis ranks #252 out of 838 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stereotaxis has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' Tariff Resilience Score compare to PDEX and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Stereotaxis ranks #252 out of 838 companies for Tariff Resilience Score. This puts Stereotaxis in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Stereotaxis's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.32, compared to a current price of $1.77 — trading 23.7% below its estimated fair value. The current Tariff Resilience Score is 4. Stereotaxis' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Stereotaxis (STXS), the current Tariff Resilience Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.77 is trading 23.7% below its estimated GF Value™ of $2.32. GuruFocus considers Stereotaxis to be Modestly Undervalued.

Key valuation signals for STXS:

  • Tariff Resilience Score: 4
  • GF Value™: $2.32 vs. price of $1.77 (23.7% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
68GF Score

Get the complete analysis for STXS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.77
Price
$2.32
GF Value